Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2393 of 6351
-
New combo therapy aims to stop ICU muscle wasting
Disease control Recruiting nowIntensive Care Unit Acquired Weakness (ICUAW) describes muscle weakness that occurs in around 40% of patients during an intensive care stay. The morbidity and mortality of these patients is significantly increased over a 5-year period. The aim of this study is to investigate the …
Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThe main purpose of the study is to evaluate the safety and tolerability of HRO761 and identify the recommended dose(s), i.e., the optimal safe and active dose of HRO761 alone or in combination with pembrolizumab or irinotecan that can be given to patients who have cancers with s…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Nasal spray could zap COVID-19 virus in the nose
Disease control OngoingThe goal of this study is to test an investigational new inhaled medication called Optate.
Phase 2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New test could predict immunotherapy success from live tumor samples
Knowledge-focused OngoingThe primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Could stenting kidney arteries lower blood pressure and protect kidneys?
Disease control Recruiting nowThe goal of this clinical trial is to document a beneficial effect of percutaneous transluminal renal angioplasty (PTRA) of atherosclerotic renal artery stenosis in high-risk patients selected according to the criteria used in the DAN-PTRA study. The main questions the trial aims…
Sponsor: University of Aarhus • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Stent showdown: which esophageal prosthesis best restores swallowing in advanced cancer?
Symptom relief Recruiting nowEsophageal cancer is the seventh most common type of cancer in the world, with an estimated global incidence of 604,100 new cases per year. The main symptom of esophageal cancer is dysphagia, associated or not with weight loss. Unfortunately, due to asymptomatic presentation in t…
Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Stem cells injected into heart arteries may help repair damage after a heart attack
Disease control Stopped earlyThis study will test the hypothesis intracoronary administration of OmniMSC-AMI (allogenic bone marrow-derived mesenchymal stem cells) just after finishing the primary percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) patients without …
Phase 1 • Sponsor: Taiwan Bio Therapeutics Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spinal stimulation device hopes to restore movement in paralyzed patients
Disease control PausedThe objectives of this study are to (1) determine the effects of neuromodulation techniques on mobility in persons with chronic SCI, as measured by subjective and objective measures, and (2) to determine the optimal combination of techniques that modify mobility and movement in a…
Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 26, 2026 14:56 UTC
-
New drug trial for painful skin condition halted early
Disease control Stopped earlyIzokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin 17A, to which it binds with high affinity. This study investigates izokibep in participants with active Hidradenitis Suppurativa (HS), including tumor necrosis factor-alpha inhibitor (T…
Phase 3 • Sponsor: ACELYRIN Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Exercise as medicine: new study tests aerobic fitness to slow memory loss
Disease control Recruiting nowThe goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible mild Alzheimer's Disease. The main questions it aims to answer are: * test the effects of aerobic exerc…
Sponsor: Arizona State University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hormone protocol could make IVF cheaper and easier for women with low egg supply
Disease control Recruiting nowOne of the barriers in patients with diminished ovarian reserve (DOR) is the significantly reduced number of oocytes resulting in fewer oocytes collected and embryos formed. Many ovarian stimulation strategies have been proposed to improve oocyte or embryo quantity which is oocyt…
Sponsor: Tam Anh TP. Ho Chi Minh General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
VR therapy gets a confidence boost to fight fear of heights
Symptom relief CompletedSelf-efficacy (SE) enhancement after virtual reality exposure (VRET) for heights can promote treatment-induced effects (Raeder et al. 2019). Raeder et al (2019) employed an intervention to enhance SE by introducing specific questions about autobiographical events of success and m…
Sponsor: Ruhr University of Bochum • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Brain pacemaker study aims to unlock sleep secrets in Parkinson's
Knowledge-focused Recruiting nowSleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and t…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New psoriasis ointment shows promise in large chinese trial
Disease control CompletedThis study is conducted to assess the efficacy and safety of LEO 90100 when used on the body for the treatment of stable plaque psoriasis in native adult Chinese subjects, compared to Daivobet® ointment.
Phase 3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Peer support could boost HIV med adherence and curb substance use
Disease control OngoingThe purpose of this study is to evaluate a stepped care behavioral intervention for HIV medication adherence and substance use ("Khanya") integrated into an HIV primary care setting in South Africa. The intervention is specifically designed to be implemented by non-specialist cou…
Sponsor: University of Maryland, College Park • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Scientists hunt for genetic signs that show which breast cancer patients will benefit from kisqali
Knowledge-focused OngoingHormone receptor (HR)-positive and HER2-negative (HR+/HER2-) metastatic/advanced breast cancer (mBC) is a major public health issue. During the last decades, a therapeutic challenge was to overcome the tumor's resistance to endocrine therapy (ET). Thanks to a better understanding…
Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New hope for tough blood cancers: experimental drug enters human testing
Disease control Stopped earlyThis study is testing the safety and tolerability of BGB-21447 monotherapy in participants with relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). The study aims to determine the maximum tolerated dose (M…
Phase 1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a diabetes drug tame Alzheimer's inflammation?
Disease control CompletedThe study is being conducted to understand how the medicine, semaglutide, affects the immune system and other biological processes in people with Alzheimer's disease. Semaglutide is a medicine that doctors can prescribe in some countries for the treatment of type 2 diabetes and e…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New heart procedure aims to improve rhythm control in persistent AF patients
Disease control OngoingSince a new method called pulsed-field ablation (PFA) has emerged, allowing significantly simpler, safer, and faster creation of ablative lesions in paroxysmal AF and PsAF (13), redefining the "optimal" ablation approach started to appear mandatory. Our project (The PIVCO study) …
Sponsor: České Budějovice Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New blood test may detect fatty liver before It's too late
Diagnosis Recruiting nowIn this initial investigator-initiated retrospective study, aim to analyze the enhanced liver fibrosis (ELF) scores in this high-risk population for NAFLD/nonalcoholic steatohepatitis(NASH)-related fibrosis. Study define 'high-risk' to include metabolic syndrome, which can be fur…
Sponsor: Methodist Health System • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC